We found no difference in the prevalence of OSA between the different galectin-3 groups, which may be attributed to the different cutoff for galectin-3 compared to previous studies and the lack of polysomnography or other objective sleep studies in our methodology to confirm diagnoses [17]. The gene discussed is LGALS3; the disease is obstructive sleep apnea syndrome.